PTCT FY 2016 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$83M+124.9% YoY

Gross Profit

-$35M-42.2% margin

Operating Income

-$132M-159.7% margin

Net Income

-$142M-171.8% margin

EPS (Diluted)

$-4.17

Cash Flow

Operating Cash Flow

-$104M

Free Cash Flow

-$105M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$269M

Total Liabilities

$150M

Stockholders' Equity

$120M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$37M	+124.9%
Gross Profit	-$35M	-$85M	+58.9%
Operating Income	-$132M	-$167M	+21.0%
Net Income	-$142M	-$170M	+16.6%